Literature DB >> 25455892

Low doses of ochratoxin A induce micronucleus formation and delay DNA repair in human lymphocytes.

Cyndia A González-Arias1, Alma B Benitez-Trinidad, Monserrat Sordo, Lourdes Robledo-Marenco, Irma M Medina-Díaz, Briscia S Barrón-Vivanco, Sonia Marín, Vicente Sanchis, Antonio J Ramos, Aurora E Rojas-García.   

Abstract

The contamination of food commodities by fungal toxins has attracted great interest because many of these mycotoxins are responsible for different diseases, including cancer and other chronic illnesses. Ochratoxin A (OTA) is a mycotoxin naturally present in food, and long-term exposure to food contaminated with low levels of OTA has been associated with renal cancer. In the present study, the cytotoxicity, cytostaticity, and genotoxicity of OTA (0.075-15 µM) in human lymphocytes were evaluated. A comet assay, a modified comet assay (DNA repair assay), which uses N-hydroxyurea (NHU) to detect non-repaired lesions produced by OTA, and a cytokinesis-blocked micronucleus assay were used. Treatments with OTA were not cytotoxic, but OTA caused a cytostatic effect in human lymphocytes at a concentration of 15 µM. OTA (0.075-5 µM) produced a slight increase in the percentage of DNA in the comets and a delay in the DNA repair capacity of the lymphocytes. Micronucleus (MN) induction was observed at OTA concentrations of 1.5 and 5 µM. Our results indicate that OTA induces DNA stable damage at low doses that are neither cytotoxic nor cytostatic, and OTA delays the DNA repair kinetics. These findings indicate that OTA affects two pivotal events in the carcinogenesis pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25455892     DOI: 10.1016/j.fct.2014.10.006

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  8 in total

1.  Mycotoxins as human carcinogens-the IARC Monographs classification.

Authors:  Vladimir Ostry; Frantisek Malir; Jakub Toman; Yann Grosse
Journal:  Mycotoxin Res       Date:  2016-11-25       Impact factor: 3.833

2.  Association between micronucleus frequency and cervical intraepithelial neoplasia grade in Thinprep cytological test and its significance.

Authors:  Yong-Hua Shi; Bo-Wei Wang; Talaf Tuokan; Qiao-Zhi Li; Ya-Jing Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

Review 3.  Ochratoxin A: 50 Years of Research.

Authors:  Frantisek Malir; Vladimir Ostry; Annie Pfohl-Leszkowicz; Jan Malir; Jakub Toman
Journal:  Toxins (Basel)       Date:  2016-07-04       Impact factor: 4.546

4.  GADD45a Regulates Olaquindox-Induced DNA Damage and S-Phase Arrest in Human Hepatoma G2 Cells via JNK/p38 Pathways.

Authors:  Daowen Li; Chongshan Dai; Xiayun Yang; Bin Li; Xilong Xiao; Shusheng Tang
Journal:  Molecules       Date:  2017-01-13       Impact factor: 4.411

5.  Cytotoxicity, Genotoxicity and Disturbance of Cell Cycle in HepG2 Cells Exposed to OTA and BEA: Single and Combined Actions.

Authors:  Ana Juan-García; Josefa Tolosa; Cristina Juan; María-José Ruiz
Journal:  Toxins (Basel)       Date:  2019-06-14       Impact factor: 4.546

Review 6.  Metabolic Disruption by Naturally Occurring Mycotoxins in Circulation: A Focus on Vascular and Bone Homeostasis Dysfunction.

Authors:  Amir Mohammad Malvandi; Sara Shahba; Jalil Mehrzad; Giovanni Lombardi
Journal:  Front Nutr       Date:  2022-06-24

7.  Can Sevoflurane Induce Micronuclei Formation in Nasal Epithelial Cells of Adult Patients?

Authors:  Elvin Kesimci; Erdem Çoşkun; Gökçer Uğur; Togay Müderris; Seval İzdeş; Bensu Karahalil
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-10-01

8.  Multiple-endpoint in vitro carcinogenicity test in human cell line TK6 distinguishes carcinogens from non-carcinogens and highlights mechanisms of action.

Authors:  Katherine E Chapman; Eleanor C Wilde; Fiona M Chapman; Jatin R Verma; Ume-Kulsoom Shah; Leanne M Stannard; Anna L Seager; James A Tonkin; M Rowan Brown; Ann T Doherty; George E Johnson; Shareen H Doak; Gareth J S Jenkins
Journal:  Arch Toxicol       Date:  2020-09-10       Impact factor: 6.168

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.